A functioning FSH-secreting pituitary macroadenoma causing an ovarian hyperstimulation syndrome with multiple cysts resected and relapsed after leuprolide in a reproductive-aged woman

References

• Snyder PJ. Gonadotroph cell adenomas of the pituitary. Endocr Rev 1985;6:552–563.
   PubMed Web of Science ®Google Scholar
• Chanson P. Gonadotroph pituitary adenomas. Ann Endocrinol (Paris) 2000;61:258–268.
   PubMed Web of Science ®Google Scholar
• Snyder PJ. Extensive personal experience: Gonadotroph adenomas. J Clin Endocrinol Metab 1995;80:1059–1061.
   PubMed Web of Science ®Google Scholar
• Snyder PJ. Clinically nonfunctioning pituitary adenomas. Endocrinol Metab Clin North Am 1993;22:163–175.
   PubMed Web of Science ®Google Scholar
• Samuels MH, Ridgway EC. Glycoprotein-secreting pituitary adenomas. Baillieres Clin Endocrinol Metab 1995;9:337–358.
   PubMedGoogle Scholar
• Daneshdoost L, Gennarelli TA, Bashey HM, Savino PJ, Sergott RC, Bosley TM, Snyder PJ. Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone β subunit response to thyrotropin-releasing hormone. J Clin Endocrinol Metab 1993;77:1352–1355.
   PubMed Web of Science ®Google Scholar
• Klibanski A, Ridgway EC, Zervas NT. Pure α subunit-secreting pituitary tumors. J Neurosurg 1983;59:585–589.
   PubMed Web of Science ®Google Scholar
• Dahlqvist P, Koskinen LO, Brännström T, Hägg E. Testicular enlargement in a patient with a FSH-secreting pituitary adenoma. Endocrine 2010;37:289–293.
   PubMed Web of Science ®Google Scholar
• Heseltine D, White MC, Kendall-Taylor P, De Kretser DM, Kelly W. Testicular enlargement and elevated serum inhibin concentrations occur in patients with pituitary macroadenomas secreting follicle stimulating hormone. Clin Endocrinol (Oxf) 1989;31:411–423.
   PubMed Web of Science ®Google Scholar
• Zárate A, Fonseca ME, Mason M, Tapia R, Miranda R, Kovacs K, Schally AV. Gonadotropin-secreting pituitary adenoma with concomitant hypersecretion of testosterone and elevated sperm count. Treatment with LRH agonist. Acta Endocrinol 1986;113:29–34.
   PubMedGoogle Scholar
• Ambrosi B, Bassetti M, Ferrario R, Medri G, Giannattasio G, Faglia G. Precocious puberty in a boy with a PRL-, LH- and FSH-secreting pituitary tumour: Hormonal and immunocytochemical studies. Acta Endocrinol 1990;122:569–576.
   PubMedGoogle Scholar
• Cooper O, Geller JL, Melmed S. Ovarian hyperstimulation syndrome caused by an FSH-secreting pituitary adenoma. Nat Clin Pract Endocrinol Metab 2008;4:234–238.
   PubMedGoogle Scholar
• Wide L, Lunderberg PO. Hypersecretion of an abnormal form of follicle-stimulating hormone associated with suppressed luteinizing hormone secretion in a woman with a pituitary adenoma. J Clin Endocrinol Metab 1981;61:580–584.
   Google Scholar
• Daneshdoost L, Gennarelli TA, Bashey HM, Savino PJ, Sergott RC, Bosley TM, Snyder PJ. Recognition of gonadotroph adenomas in women. N Engl J Med 1991;324:589–594.
   PubMed Web of Science ®Google Scholar
• Snyder PJ, Muzyka R, Johnson J, Utiger RD. Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion. J Clin Endocrinol Metab 1980;51:744–748.
   PubMed Web of Science ®Google Scholar
• Murata Y, Ando H, Nagasaka T, Takahashi I, Saito K, Fukugaki H, Matsuzawa K, Mizutani S. Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma. J Clin Endocrinol Metab 2003;88:1988–1993.
   PubMed Web of Science ®Google Scholar
• Young WF Jr, Scheithauer BW, Kovacs KT, Horvath E, Davis DH, Randall RV. Gonadotroph adenoma of the pituitary gland: A clinicopathologic analysis of 100 cases. Mayo Clin Proc 1996;71:649–656.
   PubMed Web of Science ®Google Scholar
• Castelbaum AJ, Bigdeli H, Post KD, Freedman MF, Snyder PJ. Exacerbation of ovarian hyperstimulation by leuprolide reveals a gonadotroph adenoma. Fertil Steril 2002;78:1311–1313.
   PubMed Web of Science ®Google Scholar
• Roman SH, Goldstein M, Kourides IA, Comite F, Bardin CW, Krieger DT. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and α-subunit levels in a patient with an LH-secreting pituitary tumor. J Clin Endocrinol Metab 1984;58:313–319.
   PubMed Web of Science ®Google Scholar
• Sassolas G, Lejeune H, Trouillas J, Forest MG, Claustrat B, Lahlou N, Loras B. Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 1988;67:180–185.
   PubMed Web of Science ®Google Scholar
• Davis A, Goel S, Picolos M, Wang M, Lavis V. Pituitary apoplexy after leuprolide. Pituitary 2006;9:263–265.
   PubMedGoogle Scholar
• Hands KE, Alvarez A, Bruder JM. Gonadotropin-releasing hormone agonist-induced pituitary apoplexy in treatment of prostate cancer: Case report and review of literature. Endocr Pract 2007;13:642–646.
   PubMedGoogle Scholar
• Engel G, Huston M, Oshima S, Beck C, Harsh G, Rosenthal MH, Camargo CA. Pituitary apoplexy after leuprolide injection for ovum donation. J Adolesc Health 2003;32:89–93.
   PubMed Web of Science ®Google Scholar
• Murakami T, Higashitsuji H, Yoshinaga K, Terada Y, Ito K, Ikeda H. Management of ovarian hyperstimulation due to follicle-stimulating hormone-secreting gonadotroph adenoma. BJOG 2004;111:1297–1300.
   PubMed Web of Science ®Google Scholar